Role Description
-
M&A and CAPEX Financial Leadership
-
Serve as the finance subject matter expert for FCS’s M&A efforts and CAPEX projects in partnership with business development, facilities, and operations leadership.
-
Own the analytical framework for measuring and interpreting financial performance of acquisitions & CAPEX projects in progress and post go-live, tracking business case vs. actuals.
-
Participate in integration planning to monitor expenses relative to approved business cases & update models to provide timely visibility into changing expectations.
-
Develop and refine transparent, repeatable reporting and models that explain performance and support performance evaluation vs. business cases.
-
Forecasting, Budgeting, and Planning Support
-
Lead forecasting, budgeting, and planning activities related to the M&A pipeline, CAPEX projects, and enterprise capital budget allocation.
-
Build models that support annual planning cycles, in-year forecasts, and scenario analysis.
-
Partner with stakeholders to ensure assumptions are well-supported, documented, and aligned to business realities.
-
Executive Decision Support and Reporting
-
In collaboration with cross-functional teams, build business cases in support of M&A and CAPEX projects in support of FCS’s growth.
-
Deliver concise, executive-ready reporting packages evaluating performance vs. business case expectations, explain results, and highlight risks and opportunities.
-
Build “so what” insights that help leadership understand what is changing, why it matters, and what actions may improve outcomes.
-
Tailor analyses for different leadership audiences.
-
Analytical and Strategic Support
-
Support the full range of analytical, reporting, and strategic needs in support of FCS’s growth.
-
Contribute to ad hoc analyses, business cases, profitability reviews, strategic planning efforts, and leadership requests.
-
Help prioritize opportunities to improve financial performance.
-
Ensure outputs are auditable and easy for stakeholders to interpret.
-
Continuous Improvement and Cross-Functional Collaboration
-
Partner across finance, operations, and practice leadership to identify opportunities for process improvement and stronger performance management – in particular as it relates to post go-live & CAPEX project postmortems.
-
Recommend enhancements to underwriting, analytical and integration approaches to improve decision support and outcomes over time.
Qualifications
-
Bachelor’s degree required; advanced degree (MBA, MS or similar) in finance, analytics or related field preferred.
-
CFA a plus.
Requirements
-
7+ years of progressive experience in M&A, corporate development, PE, FP&A, financial modeling, or analytics, with a demonstrated track record of leading complex transactions, integrations, and CAPEX initiatives in a large, matrixed organization.
-
Experience collaborating with C-suite executives & across multiple functions to affect solutions.
-
Excellent financial modeling & problem-solving skills.
-
Executive presence and experience with presentations to various leadership levels.
-
Ability to provide strategic recommendations and influence stakeholders to make decisions.
Benefits
-
Competitive salaries and comprehensive benefits packages.
-
Tuition reimbursement.
-
401-K match.
-
Pet and legal insurance.
Company Description
Since 1984, Florida Cancer Specialists & Research Institute (FCS) has built a national reputation for excellence. With over 250 physicians, 220 nurse practitioners and physician assistants and nearly 100 locations in our network. Utilizing innovative clinical research, cutting-edge technologies, and advanced treatments, we are committed to providing world-class cancer care.
We are recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. Our patients have access to ground-breaking therapies, in a community setting, and may participate in national clinical research studies of drugs and treatment protocols.
Through our partnership with Sarah Cannon, we are one of the largest clinical research organizations in the United States. Often, FCS leads the nation in initiating research studies and offering ground-breaking new therapies to patients.